Tag Archives: The Stem Cell Blog

The future of stem cell therapy in Texas – WOAI

Continue reading

2017-09-26 NEWS

WOAI

The future of stem cell therapy in Texas
WOAI
News 4 San Antonio also reached out to the University of Texas Health Science Center at San Antonio, in a statement , a spokesperson says, “Research of adult stem cells at UT Health San Antonio is preclinical (not in humans), and the institution is

and more »

Continue reading

2017-09-26 NEWS

WCVB Boston

Cancer treatment tested in Boston under review by the FDA
WCVB Boston
“I think we’re on the cusp of something revolutionary,” Johnson said. “You don’t want to throw that “cure” word out, but really feel like that’s a distinct possibility, so much so that we actually didn’t refer these patients for any other therapy after

and more »

Continue reading

2017-09-25 NEWS

Scope (blog)

Immune cells release “red flag” to activate muscle stem cells in response to damage
Scope (blog)
Muscle stem cells are wily beasts. As I’ve written about before, they nestle along our muscle fibers and quietly await the biological red flag that will tell them to leap into action and form new muscle fibers. But exactly how they are activated

Continue reading

2017-09-25 NEWS

Scope (blog)

Immune cells release “red flag” to activate muscle stem cells in response to damage
Scope (blog)
Muscle stem cells are wily beasts. As I’ve written about before, they nestle along our muscle fibers and quietly await the biological red flag that will tell them to leap into action and form new muscle fibers. But exactly how they are activated

Continue reading

2017-09-25 NEWS

pharmaphorum

JAMA Commentary Urges Realistic View of New CAR T-Cell Cancer Therapy
AJMC.com Managed Markets Network
The 3 oncologists from Memorial Sloan Kettering Cancer Center acknowledged the “impressive science” behind the therapy marketed as Kymriah, which involves genetically modifying each patient’s chimeric antigen receptor (CAR) T cells to target and kill …
Premium price for Novartis’ CART sparks pushback from top PBMBioPharma Dive

all 6 news articles »